Blog: Engaging Innovation | Friends of Cancer Research

Authored on

And

July 15, 2021

How Will Expanded Eligibility Criteria Improve Access to Clinical Trials for Patients with Cancer?

Creating a New Cancer Research Paradigm by Broadening Eligibility Criteria The American Society of Clinical Oncology (ASCO, a professional society for cancer clinicians and researchers) and Friends…

Learn more

July 7, 2021

How Will Expanded Eligibility Criteria Impact Clinical Trial Design?

Learn more

May 21, 2021

How Will Expanding Eligibility Criteria Impact Clinical Trial Study Design?

Learn more

Grace Collins | April 23, 2021

Data Driven Insights - Accelerated Approval

Since 1992, Accelerated Approval has facilitated earlier patient access to promising therapies that treat serious and life-threatening illnesses. While a traditional approval is often based on a…

Learn more

April 14, 2021

Watch Now: Discussion on Eligibility Criteria and the Impact on Access to Clinical Trials

On Friday, April 9, ASCO and Friends of Cancer Research (Friends) co-hosted a live virtual event, which brought together experts from across the healthcare sector to discuss the recent release of the…

Learn more

Grace Collins | February 17, 2021

Shaping the Future of Emerging Immunotherapies and Cell Therapies

On February 11, 2021, Friends of Cancer Research (Friends) hosted a virtual meeting highlighting and discussing the progress, challenges, and future of immunotherapies and cell therapies. Ellen Sigal…

Learn more

Eric Hua | November 23, 2020

Friends Annual Meeting Day 2: Optimizing the Use of Accelerated Approval Meeting Summary

The second of two sessions for the Friends of Cancer Research (Friends) Annual Meeting was held on November 19th. Day 2 featured a shift from Modernizing Expedited Development Pathways to a focus on…

Learn more